Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VSL#3 for Portal Hypertension in Decompensated Cirrhosis
NCT01032941Phase 2Completed
- Sponsor
- University of Alberta
- Start
- Dec 2009
- Primary completion
- Jun 2011
- Modality
- Multi-strain Products
- Countries
- 1
01
Overview
A Phase 2 trial of VSL#3 in Portal Hypertension (PH), sponsored by University of Alberta. Started Dec 2009; status: completed.
02
Drugs
VSL#3
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT01032941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01032941.